{"id":9173,"date":"2018-01-08T13:26:25","date_gmt":"2018-01-08T18:26:25","guid":{"rendered":"https:\/\/geiselmed.dartmouth.edu\/news\/?p=9173"},"modified":"2018-01-08T14:12:34","modified_gmt":"2018-01-08T19:12:34","slug":"james-bliska-to-lead-dartmouth-cystic-fibrosis-research-cluster","status":"publish","type":"post","link":"https:\/\/geiselmed.dartmouth.edu\/news\/2018\/james-bliska-to-lead-dartmouth-cystic-fibrosis-research-cluster\/","title":{"rendered":"James Bliska to Lead Dartmouth Cystic Fibrosis Research Cluster"},"content":{"rendered":"
\"\"
James Bliska, PhD (photo by Rob Strong)<\/figcaption><\/figure>\n

Noted molecular biologist James Bliska, PhD, is joining the Geisel School of Medicine at Dartmouth as a Distinguished Professor in Microbiology and Immunology and senior lead faculty member of the Personalized Treatments for Cystic Fibrosis (CF) Cluster<\/a>, a cross-Dartmouth group of investigators established to develop innovative, personalized medicine and treatments for CF and lung infections caused by opportunistic pathogens.<\/p>\n

\u201cI am very excited to have Dr. Bliska joining our faculty and leading the development of the Personalized Treatments for Cystic Fibrosis Cluster,\u201d says Duane Compton, PhD, dean of Geisel. \u201cI look forward to working with Dr. Bliska and Dr. Bruce Stanton, director of Geisel\u2019s Lung Biology Center, in building an interdisciplinary team to develop a deeper understanding and more effective therapeutic strategies for disorders like CF, which involves a complex combination of genetic predisposition, epithelial cell biology, and pathogens.\u201d<\/p>\n

Bliska was formerly a professor of molecular genetics and microbiology at Stony Brook University where he directed both the Center for Infectious Diseases and the Molecular and Cell Biology of Infectious Disease Training Program for graduate students. He begins work in Hanover in January.<\/p>\n

\u201cI\u2019m very excited to join Geisel and the Department of Microbiology and Immunology,\u201d says Bliska. \u201cThe highly collaborative environment and excellent scientists in that department, and the leadership of Bill Green, are well-known to me and made this a great opportunity. The Lung Biology Center, headed by Bruce Stanton, is also a highly collaborative, interdisciplinary group of scientists working in the area that I\u2019m interested in, and I\u2019m thrilled to be a part of that, as well.\u201d<\/p>\n

Bliska\u2019s research has been focused on understanding how bacterial toxins interact with the immune system to trigger pathogenesis or host protection. At Dartmouth, he will expand his research to investigate opportunistic bacterial pathogens that produce toxins and cause mucosal infections, such as those that occur in the lungs of CF patients.<\/p>\n

\u201cI think Jim\u2019s impact here will be profound in two major ways,\u201d says William Green, PhD, the Elmer R. Pfefferkorn Professor and chair of the Department of Microbiology and Immunology at Geisel. \u201cThe first is that he\u2019s an excellent researcher with high-impact publications and a terrific track record of funding from the NIH as a principal investigator. Secondly, he will bring in expertise and knowledge that will leverage some of the great interdisciplinary work being done across Dartmouth\u2014a \u2018team science\u2019 approach that is crucial to tackling complex disease processes like CF.\u201d<\/p>\n

\"The goal will be to create a world-class research group that will study infections of the lung by opportunistic pathogens, especially in CF patients.\"<\/span><\/span><\/p>\n

- James Bliska<\/span><\/p>\n<\/blockquote>\n

Funded by a generous endowment from an anonymous donor, the Personalized Treatments for Cystic Fibrosis Cluster is one of 10 interdisciplinary academic groups formed as part of Dartmouth College President Phil Hanlon\u2019s goal of strengthening academic excellence at Dartmouth. The cluster initiative<\/a> is aimed at extending Dartmouth\u2019s impact on the world through interdisciplinary faculty teams who collaborate at the leading edge of discovery.<\/p>\n

\u201cThe vision for the cluster is coming together and involves the hiring of two additional junior faculty,\u201d says Bliska. \u201cThe goal will be to create a world-class research group that will study infections of the lung by opportunistic pathogens, especially in CF patients. We\u2019re interested in understanding how the diseases occur and in developing therapeutics. It\u2019s also conceivable that in the near future, it\u2019s going to be possible to take advantage of cutting-edge genome editing techniques to correct the CF mutation in patients for the first time, and we\u2019re hoping to be part of that.\u201d<\/p>\n

Bliska received a BS in bacteriology at the University of Wisconsin-Madison in 1983. He completed his PhD in molecular biology from the University of California-Berkeley in 1988, and did his postdoctoral training in bacterial pathogenesis at Stanford University. In 1993, Bliska joined Stony Brook University as an assistant professor of molecular genetics and microbiology. He was appointed an associate professor with tenure in 1999, and professor in 2003. He has been actively involved in teaching graduate-level courses and scientific mentoring of undergraduates and high school students throughout his career.<\/p>\n

Bliska was the recipient of a Pew Scholar Award in 1994. He also became a Fellow of the American Academy of Microbiology in 2012, a Fellow of the American Association for the Advancement of Science in 2013, and received the Dean\u2019s Award for Excellence in Graduate Mentoring at Stony Brook in 2015.<\/p>\n

Born in Colorado and raised in Colorado and Minnesota, Bliska enjoys a variety of outdoor activities, such as skiing and hiking, with his wife Janice and his daughters Emma and Hanna, who are attending Middlebury College and Dartmouth College respectively.<\/p>\n

About the Geisel School of Medicine at Dartmouth<\/strong><\/p>\n

Founded in 1797, the Geisel School of Medicine at Dartmouth strives to improve the lives of the communities it serves through excellence in learning, discovery, and healing. The Geisel School of Medicine is renowned for its leadership in medical education, health care policy and delivery science, biomedical research, global health, and in creating innovations that improve lives worldwide. As one of America\u2019s leading medical schools, Dartmouth\u2019s Geisel School of Medicine is committed to training new generations of diverse leaders who will help solve our most vexing challenges in health care.<\/p>\n

 <\/p>\n","protected":false},"excerpt":{"rendered":"

Noted molecular biologist James Bliska, PhD, is joining the Geisel School of Medicine at Dartmouth as a Distinguished Professor in Microbiology and Immunology and senior lead faculty member of the Personalized Treatments for Cystic Fibrosis (CF) Cluster<\/a>, a cross-Dartmouth group of investigators established to develop innovative, personalized medicine and treatments for CF and lung infections caused by opportunistic pathogens.<\/p>\n","protected":false},"author":26,"featured_media":9174,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"jetpack_post_was_ever_published":false,"_jetpack_newsletter_access":"","_jetpack_dont_email_post_to_subs":false,"_jetpack_newsletter_tier_id":0,"_jetpack_memberships_contains_paywalled_content":false,"_jetpack_memberships_contains_paid_content":false,"footnotes":"","jetpack_publicize_message":"","jetpack_publicize_feature_enabled":true,"jetpack_social_post_already_shared":true,"jetpack_social_options":{"image_generator_settings":{"template":"highway","default_image_id":0,"font":"","enabled":false},"version":2}},"categories":[1,182,8],"tags":[610,674,38,847,320],"class_list":["post-9173","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-news","category-press-release-news","category-research","tag-academic-cluster","tag-cystic-fibrosis","tag-faculty","tag-home-feature","tag-research-2","author-26"],"jetpack_publicize_connections":[],"jetpack_featured_media_url":"https:\/\/geiselmed.dartmouth.edu\/news\/wp-content\/uploads\/sites\/2\/2018\/01\/bliska-050-nc.jpg","jetpack_sharing_enabled":true,"jetpack_shortlink":"https:\/\/wp.me\/p4r3h1-2nX","_links":{"self":[{"href":"https:\/\/geiselmed.dartmouth.edu\/news\/wp-json\/wp\/v2\/posts\/9173","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/geiselmed.dartmouth.edu\/news\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/geiselmed.dartmouth.edu\/news\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/geiselmed.dartmouth.edu\/news\/wp-json\/wp\/v2\/users\/26"}],"replies":[{"embeddable":true,"href":"https:\/\/geiselmed.dartmouth.edu\/news\/wp-json\/wp\/v2\/comments?post=9173"}],"version-history":[{"count":10,"href":"https:\/\/geiselmed.dartmouth.edu\/news\/wp-json\/wp\/v2\/posts\/9173\/revisions"}],"predecessor-version":[{"id":9225,"href":"https:\/\/geiselmed.dartmouth.edu\/news\/wp-json\/wp\/v2\/posts\/9173\/revisions\/9225"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/geiselmed.dartmouth.edu\/news\/wp-json\/wp\/v2\/media\/9174"}],"wp:attachment":[{"href":"https:\/\/geiselmed.dartmouth.edu\/news\/wp-json\/wp\/v2\/media?parent=9173"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/geiselmed.dartmouth.edu\/news\/wp-json\/wp\/v2\/categories?post=9173"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/geiselmed.dartmouth.edu\/news\/wp-json\/wp\/v2\/tags?post=9173"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}